Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer    PFE

PFIZER (PFE)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Latest Tweets
03:24aTraders Buy Shares of Pfizer, Inc. $PFE on Weakness  
01:04aDow Jones Analysis Video - $DJIA $DIA $SDOW $XOM $GE $GS $MRK $PFE $BMY $VZ .. 
10/16And Neel Lilani will interview Elaine Jones of Pfizer Venture Investments on .. 
10/16Peores del Dow Jones: Walmart, Pfizer, American Express...
1
10/16Will more drug makers file antitrust lawsuits against rivals? Mike Carrier ex.. 
10/16What is the real reason Pfizer wants out of consumer health? -- Heard on the ..
5
10/16After getting skunked by rivals, Pfizer touts ‘breakthrough’ cancer drug lorl.. 
10/16$PFE aims "breakthrough" ALK inhibitor lorlatinib at NSCLC, looks to regulato..
3
10/16
1
10/16  
10/16  
10/16Pfizer's lorlatinib shows treatment effect in mid-stage lung cancer study  
10/16Pfizer given $38.00 PT by Jefferies Group LLC. neutral rating.  
10/16Pharmalot.. Pharmalittle.. Good Morning.. headlines & coffee are served.... 
10/16After getting skunked by rivals, Pfizer touts ‘breakthrough’ cancer drug lorl..
1
10/16BRIEF-Pfizer presents results from Phase 2 study of investigational ALK-inhib.. 
10/16Pfizer Presents Full Results from Phase 2 Study of Next-Generation Investigat.. 
10/16Pfizer Presents Full Results from Phase 2 Study of Next-Generation Investigat.. 
10/16Get ready for precision and invasive pharmaceutical ads $PFE  
10/16Pfizer Presents Full Results from Phase 2 Study of Next-Generation Investigat.. 
10/16@ SMIpharm: RT PharmaMKTnet: Learn how to build integrated, impactful social .. 
10/16Pfizer, Inc. $PFE Shares Sold by Arthur M. Cohen & Associates LLC  
10/16Learn how to build integrated, impactful social media strategies with Pfizer ..
2
10/16Diamond Hill Capital Management Inc. Sells 1,026,345 Shares of Pfizer, Inc. $.. 
10/15  
10/15Glaxo might want to make a bid for Pfizer's consumer unit (home of Advil and ..
1
10/15Pfizer, Inc. $PFE Stake Lifted by Cortland Associates Inc. MO  
10/156,272 Shares in Pfizer, Inc. $PFE Acquired by Park Avenue Securities LLC  
10/15Public Employees Retirement Association of Colorado Has $101.21 Million Stake.. 
10/15Get ready for precision and invasive pharmaceutical ads $PFE  
10/14Barclays PLC Reiterates $38.00 Price Target for Pfizer, Inc. $PFE  
10/14Just in time for flu season, Pfizer Inc. wants to sell Emergen-C
2
10/13Allergan settles Restasis litigation with Pfizer's InnoPharma as backlash mou.. 
10/13Healthcare + A.I. at Pfizer on Nov. 2: Here’s the Agenda #xconhealthAI |  
10/13Merck KGaA, Darmstadt, Germany & Pfizer’s immunotherapy receives FDA Orph..
2
10/13Reckitt Benckiser is the most likely buyer of Pfizer’s Consumer Healthcare bu.. 
10/13Get ready for precision and invasive pharmaceutical ads $PFE  
10/13With a year left before generics hit, Pfizer nabs FDA approval for new-and-im.. 
10/13Pfizer: Could a Big Merger Move the Needle?  
10/13Pharmalot.. Pharmalittle.. Good Morning.. headlines, weekend daydreams & .. 
10/13Former FDA commish Mark McLennan bringing $ONCE $BLUE $PFE together w/ insure..
23
10/13With a year left before generics hit, Pfizer nabs FDA approval for new-and-im.. 
10/13Congrats to our Knoxville Idol winner, John Young! #WATE  
10/13Dow Jones Analysis Video - $DJIA $DIA $SDOW $XOM $GE $GS $MRK $PFE $BMY $VZ .. 
10/12With a year left before generics hit, Pfizer nabs FDA approval for new-and-im..
4
10/12Sell these #dividend #stocks now on big risks  
10/12With a year left before generics hit, $PFE nabs FDA approval for new-and-impr.. 
10/12A Deep Dive Into MannKind's Big Bet On Afrezza  
10/12DA Davidson says Pfizer announcement creates M&A opportunity for Prestige..
2
10/12bought some $PFE 36.55 
More tweets
Qtime:425
Financials ($)
Sales 2017 52 680 M
EBIT 2017 19 837 M
Net income 2017 12 051 M
Debt 2017 24 101 M
Yield 2017 3,53%
P/E ratio 2017 19,53
P/E ratio 2018 17,17
EV / Sales 2017 4,57x
EV / Sales 2018 4,37x
Capitalization 216 B
Chart PFIZER
Duration : Period :
Pfizer Technical Analysis Chart | PFE | US7170811035 | 4-Traders
Technical analysis trends PFIZER
Short TermMid-TermLong Term
TrendsBullishBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 38,2 $
Spread / Average Target 5,0%
EPS Revisions
Managers
NameTitle
Ian C. Read Chairman & Chief Executive Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
W. Don Cornwell Independent Director
Dennis Arthur Ausiello Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER11.88%216 409
JOHNSON & JOHNSON18.42%366 178
NOVARTIS13.23%225 160
ROCHE HOLDING LTD.5.20%216 764
MERCK AND COMPANY7.68%172 887
AMGEN25.17%133 538